phosphoenolpyruvate has been researched along with Cardiometabolic Syndrome in 1 studies
Phosphoenolpyruvate: A monocarboxylic acid anion derived from selective deprotonation of the carboxy group of phosphoenolpyruvic acid. It is a metabolic intermediate in GLYCOLYSIS; GLUCONEOGENESIS; and other pathways.
phosphoenolpyruvate : A monocarboxylic acid anion resuting from selective deprotonation of the carboxy group of phosphoenolpyruvic acid.
phosphoenolpyruvic acid : A monocarboxylic acid that is acrylic acid substituted by a phosphonooxy group at position 2. It is a metabolic intermediate in pathways like glycolysis and gluconeogenesis.
Cardiometabolic Syndrome: A cluster of symptoms that are risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components not only include metabolic dysfunctions of METABOLIC SYNDROME but also HYPERTENSION, and ABDOMINAL OBESITY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lv, XC | 1 |
| Wu, Q | 1 |
| Yuan, YJ | 1 |
| Li, L | 1 |
| Guo, WL | 1 |
| Lin, XB | 1 |
| Huang, ZR | 1 |
| Rao, PF | 1 |
| Ai, LZ | 1 |
| Ni, L | 1 |
1 other study available for phosphoenolpyruvate and Cardiometabolic Syndrome
| Article | Year |
|---|---|
Organic chromium derived from the chelation of Ganoderma lucidum polysaccharide and chromium (III) alleviates metabolic syndromes and intestinal microbiota dysbiosis induced by high-fat and high-fructose diet.
Topics: Acetyl-CoA Carboxylase; alpha-Linolenic Acid; Animals; Bile Acids and Salts; Biomarkers; Blood Gluco | 2022 |